Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS · BSE: 544222 · Pharmaceuticals & Biotechnology · 35 announcements

Share price: ₹826.50
Market cap: ₹13,009 Cr
Revenue (annual): ₹4,359 Cr
Net profit (annual): ₹255.2 Cr
P/E (TTM): 44.6×Sector 47.4×
Promoter holding: 75.26%+0.00% QoQ
FII holding: 1.91%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 6 Earnings Call 5 Legal & Regulatory 4 Financial Results 3 Adverse Business Impact 3 Results Update 2 Management Change 2 Board Meeting Date 2 Merger & Restructuring 1 Fund Raise 1 Credit Rating 1 Capacity Expansion 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Apr 2026 17:49 IST BSE

Capacity Expansion

Akums Drugs & Pharmaceuticals Capacity Expansion

Akums Drugs' wholly-owned subsidiary, Pure and Cure Healthcare, executed a lease deed on April 28, 2026, to purchase a 4050 Sq. Mtr industrial plot in Haridwar. Located adjacent to existing facilities, the plot will support business operations.

Read the filing ↗